RESTRICTED STOCK PURCHASE AGREEMENTRestricted Stock Purchase Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of the 16th day of August, 2004, by and between Tengion, Inc., a Delaware corporation (the “Corporation”), and Tim Bertram, Ph.D., D.V.M (the “Equity Participant”).
RESEARCH AGREEMENTResearch Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • North Carolina
THIS RESEARCH AGREEMENT (the “Agreement”) is made effective as of January 1, 2006 (the “Effective Date”), by and between TENGION, INC., a corporation organized under the laws of the State of Delaware, whose offices are located at 2200 Renaissance Boulevard, Suite 150, King of Prussia, Pennsylvania 19406 (hereinafter “Tengion”), and WAKE FOREST UNIVERSITY HEALTH SCIENCES, an educational institution organized under the laws of the State of North Carolina, whose offices are located on Medical Center Boulevard, Winston-Salem, North Carolina 27157 (“WFUHS” and, together with Tengion, the “Parties” or individually a “Party”).
LEASE AGREEMENT BY AND BETWEEN: NORRITON BUSINESS CAMPUS, L.P. (“LESSOR”) AND TENGION, INC. (“LESSEE”) Dated: February 1, 2006Lease Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
EXCLUSIVE LICENSE AGREEMENT BETWEEN CHILDREN’S MEDICAL CENTER CORPORATION AND TENGION, INC.Exclusive License Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • Massachusetts
This Agreement is made and entered into as of the date last written below (the “Effective Date”), by and between CHILDREN’S MEDICAL CENTER CORPORATION, a charitable corporation duly organized and existing under the laws of the Commonwealth of Massachusetts and having its principal office at 300 Longwood Avenue, Boston, Massachusetts, 02115, U.S.A. (hereinafter referred to as “CMCC”), and Tengion, Inc., a business corporation organized and existing under the laws of the State of Delaware and having its principal office c/o Scheer & Company, 250 West Main Street, Branford, Connecticut, 06405 (hereinafter referred to as “Licensee”).
LICENSE AGREEMENTLicense Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • North Carolina
This License Agreement (this “Agreement”) effective as of January 1, 2006 (the “Effective Date”), is by and between WAKE FOREST UNIVERSITY HEALTH SCIENCES, an educational institution organized under the laws of the State of North Carolina and having its principal offices at Medical Center Boulevard, Winston-Salem, North Carolina 27157 (“WFUHS”), and TENGION, INC., a Delaware corporation having its principal offices at 2200 Renaissance Boulevard, Suite 150, King of Prussia, Pennsylvania 19406 (“Tengion” and together with WFUHS, the “Parties” or individually a “Party”).
LICENSE AGREEMENT AMENDMENT NO. 1 May 3, 2007License Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT No. 1, dated as of the date shown above, is entered into by and between WAKE FOREST UNIVERSITY HEALTH SCIENCES, a North Carolina educational institution (“WFUHS”) and TENGION, INC., a Delaware corporation (“Tengion”), for the purpose of amending the License Agreement dated as of January 1, 2006 between the parties (the “License Agreement”).
TENGION, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • Delaware
THIS RESTRICTED STOCK AGREEMENT (this “Agreement”) is entered into as of the 26th day of May, 2004, by and between Tengion, Inc., a Delaware corporation (the “Corporation”), and Steven Nichtberger (the “Lender”).
LEASE AGREEMENTLease Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
THIS LEASE AGREEMENT (“Lease”), made this 8th day of June, 2005, by and between 3929 WESTPOINT INDUSTRIAL, LLC, a Delaware limited liability company, (“Landlord”) and TENGION, INC., a Delaware corporation, (“Tenant”), provides as follows:
AMENDMENT AGREEMENTAmendment Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT AGREEMENT (this “Amendment”) is made this 28th day of December 2006 by and between Tengion, Inc. (referred to as “Debtor”) and Oxford Finance Corporation (“Secured Party”) with respect to the following facts:
AMENDMENT AGREEMENTAmendment Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT AGREEMENT (this “Amendment”) is made this 3rd day of April 2006 by and between Tengion, Inc. (referred to as “Debtor”) and Oxford Finance Corporation (“Secured Party”) with respect to the following facts:
MASTER SECURITY AGREEMENT No. 5081099 Dated as of July 20, 2005 (“Agreement”)Master Security Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances) • Virginia
THIS AGREEMENT is between Oxford Finance Corporation (together with its successors and assigns, if any, “Secured Party”) and Tengion, Inc. (“Debtor”). Secured Party has an office at 133 N. Fairfax Street, Alexandria, VA 22314. Debtor is a corporation organized and existing under the laws of the state of Delaware. Debtor’s mailing address and chief place of business is 2200 Renaissance Boulevard, Suite 150, King of Prussia, PA 19406.
SUB-SUBLEASE AGREEMENTSub-Sublease Agreement • January 29th, 2010 • Tengion Inc • Biological products, (no disgnostic substances)
THIS SUB-SUBLEASE AGREEMENT (this “Sub-Sublease”) has been executed as of the 1st day of February, 2006, between CORPORATE INTERIORS, INC., a Pennsylvania corporation, whose address is 223 Lisa Drive, Newcastle, Delaware 19720-4193 (“Corporate Interiors”) and TENGION, INC., a Delaware corporation whose address is 2200 Renaissance Boulevard, Suite 150, King of Prussia, Pennsylvania 19406 (“Tengion”).
December 2, 2004 Steven NichtbergerTengion Inc • January 29th, 2010 • Biological products, (no disgnostic substances)
